Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND)

2021 ◽  
Author(s):  
Alessandro Nini ◽  
Matthias Boschheidgen ◽  
Andreas Hiester ◽  
Christian Winter ◽  
Gerald Antoch ◽  
...  
Keyword(s):  
Vascular Surgery ◽  
Testicular Cancer ◽  
Tumor Resection ◽  
Residual Tumor ◽  
Residual Tumor Resection ◽  
Major Vascular Surgery

Post-chemotherapy residual tumor resection in patients with elevated tumor markers

2021 ◽  
Vol 79 ◽  
pp. S910
Author(s):  
Y. Che ◽  
C. Winter ◽  
R. Große Siemer ◽  
A. Hiester ◽  
P. Albers
Keyword(s):  
Tumor Markers ◽  
Tumor Resection ◽  
Residual Tumor ◽  
Residual Tumor Resection

Residual Tumor Resection After High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Cancer

2004 ◽  
Vol 22 (18) ◽  
pp. 3713-3719 ◽  
Author(s):  
O. Rick ◽  
C. Bokemeyer ◽  
S. Weinknecht ◽  
J. Schirren ◽  
T. Pottek ◽  
...  
Keyword(s):  
Germ Cell ◽  
Mature Teratoma ◽  
Univariate Analysis ◽  
Cell Cancer ◽  
Tumor Resection ◽  
Residual Tumor ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Incomplete Resection ◽  
Residual Tumor Resection

Purpose To assess the role of residual tumor resection performed after high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ cell tumors (GCT). Patients and Methods Between July 1987 and October 1999, postchemotherapy resections of residual tumors were performed in 57 patients who had been treated with HDCT for relapsed or refractory GCT and who had achieved a partial remission to this treatment. Results Complete resections of residual masses were achieved in 52 (91%) of 57 patients who were rendered disease free; in five (9%) of 57 patients, the resections were incomplete. Resection of a single site was performed in 39 (68%) of 57 patients, and the remaining 18 (32%) of 57 patients required interventions at two or more residual tumor sites. Necrosis was found in 22 (38%) of 57 patients, mature teratoma with or without necrosis was found in nine (16%) of 57 patients, and viable cancer with or without additional necrosis or mature teratoma was found in 26 (46%) of 57 patients. Viable cancer consisted either of residual germ cell or undifferentiated cancer in 22 (85%) of 26 patients, with additional non-GCT histologies in the remaining four patients. Patients with viable cancer had a significantly inferior outcome after surgery compared with patients with necrosis and/or mature teratoma even if all cancer was completely resected. Pulmonary lesions with a diameter of more than 2 cm were the only predictive variable for viable cancer in univariate analysis. Conclusion Resections of all residual tumors should be attempted in patients with relapsed or refractory GCT and partial remissions after HDCT.

The Role of Residual Tumor Resection in the Management of Nonseminomatous Germ Cell Cancer of Testicular Origin

2012 ◽  
Vol 60 (06) ◽  
pp. 405-412 ◽  
Author(s):  
Joachim Schirren ◽  
Stephan Trainer ◽  
Michael Eberlein ◽  
Anja Lorch ◽  
Jörg Beyer ◽  
...  
Keyword(s):  
Germ Cell ◽  
Cell Cancer ◽  
Tumor Resection ◽  
Residual Tumor ◽  
Germ Cell Cancer ◽  
Residual Tumor Resection
Sign in / Sign up

Export Citation Format

Share Document